Dietary Modulation of Omega-3/Omega-6 Polyunsaturated Fatty Acid Ratios in Patients With Breast Cancer

Dilprit Bagga(University of California, Los Angeles), John A. Glaspy(University of California, Los Angeles), Silvana Capone(University of California, Los Angeles), Hu Wang(Peking University), David Heber(University of California, Los Angeles), Maria Lill(University of California, Los Angeles), Linnea Chap(University of California, Los Angeles)
JNCI Journal of the National Cancer Institute
August 6, 1997
10.1093/jnci/89.15.1123
Cited by 91

Related Papers

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
|British Journal of Cancer|2010|234
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo
|International Journal of Oncology|2008|119
Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy
|Nature Metabolism|2024|95
Incidence of Tumor-Cell Contamination in Leukapheresis Products of Breast Cancer Patients Mobilized With Stem Cell Factor and Granulocyte Colony-Stimulating Factor (G-CSF) or With G-CSF Alone
|Blood|1999|57
Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.
|Journal of Clinical Oncology|2017|8